-
Posted by
Two Blokes Jun 11 -
Filed in
Stock
-
6 views
Verici Dx PLC (AIM:VRCI) is preparing to raise new equity funding as it looks to ramp up the commercial rollout of its flagship transplant diagnostic, Tutivia, in the US following a key Medicare coverage decision. The London-listed diagnostics firm said it had received early support from institutional backers and other investors for the planned fundraising, which will include a placing and a retail offer for existing shareholders.
